Sio Capital Management LLC 13D/13G Filings for Salarius Pharmaceuticals, Inc. (SLRX)

Sio Capital Management LLC 13D and 13G filings for Salarius Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-10
4:05 pm
Sale
2021-12-3113GSalarius Pharmaceuticals, Inc.
SLRX
Sio Capital Management LLC6,771
3.000%
-1,515decrease
(-18.28%)
Filing
2021-02-16
1:03 pm
Purchase
2020-12-3113GSalarius Pharmaceuticals, Inc.
SLRX
Sio Capital Management LLC8,286
8.350%
8,286increase
(New Position)
Filing